| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-08 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-05 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.15 | 0.0009 |